Antiparasitic Drugs Market Size, Share & Trends Analysis Report, By Drug Type (Anthelmintics, Antiprotozoals, Others), By Route Of Administration (Oral, Injectables, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and By Region, And Segment Forecasts, Till : 2030

Report ID : AMR1004985 | Industries : Healthcare | Published On :January 2024 | Page Count : 232

Antiparasitic Drugs Market Size, Share & Trends Analysis Report, By Drug Type (Anthelmintics, Antiprotozoals, Others), By Route Of Administration (Oral, Injectables, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and By Region, And Segment Forecasts, Till – 2030

Market Overview

According to Analytical Market Research, the global Antiparasitic Drugs market estimated at USD 18 billion in 2022 and which expected, at a compound annual growth rate (CAGR) of 5% from 2023 to 2030. Key players in the Antiparasitic Drugs market employ various strategies to maintain and enhance their market presence. These strategies help key players capture a significant market share and remain competitive in the dynamic Antiparasitic Drugs market. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated includes proficient analysis, predictive analysis, prescriptive analysis, cumulative analysis, and value chain analysis.

ANTIPARASITIC DRUGS MARKET DYNAMICS: KEY DRIVERS & RESTRAINTS

Advancements in Research and Development (R&D)
Ongoing advancements in research and development within the pharmaceutical industry are a key driver for the antiparasitic drugs market. The discovery of novel drug compounds, improved formulations, and the identification of new therapeutic targets contribute to the development of more effective and targeted antiparasitic medications. These innovations enhance treatment options, efficacy, and patient outcomes, driving market growth.
Drug Resistance and Limited Treatment Options
One significant restraint in the antiparasitic drugs market is the emergence of drug resistance in various parasitic organisms. Over time, parasites can develop resistance to commonly used antiparasitic medications, limiting the effectiveness of existing treatments. Additionally, the limited availability of alternative treatment options poses a challenge in managing parasitic infections, especially in regions where drug resistance is prevalent. This constraint underscores the need for ongoing research to develop new drugs and strategies to combat resistance.

How are Segments Performing in the Global Antiparasitic Drugs Market?

Antiparasitic Drugs Drug Type Segment Breakdown
According to Analytical Market Research, the Antiparasitic Drugs market by Drug Type is segmented into Anthelmintics, Antiprotozoals, Others.
Antiparasitic Drugs Route Of Administration Segment Breakdown
According to Analytical Market Research, based on Route Of Administration, the market is segmented into Oral, Injectables, and Topical.
Antiparasitic Drugs Distribution Channel Segment Breakdown
According to Analytical Market Research, based on Distribution Channel the market is segmented into Hospital Pharmacies, Retail Pharmacies, Others.
Antiparasitic Drugs Geographic Exploration
According to Analytical Market Research, the North America region is predicted to dominate the market, owing to the rise in the automotive industry in the region. Other regions competing in the market are North America, Europe, Middle East and Africa and Latin America respectively.

COMPETITIVE LANDSCAPE & RECENT DEVELOPMENT: Antiparasitic Drugs

The significant players rapidly evolve with new strategies to attain a competitive edge and capture significant market share.
• For Instance, in May 2022, May & Baker Nigeria PLC launched Artelum Combo, a novel drug developed to battle malaria parasites across the country. This medication includes Arthemeter Lumefantrine and Paracetamol, providing a complete malaria therapy in a single, compact container.

Noticeable Players Functioning in The Global Antiparasitic Drugs Market Include:

• GlaxoSmithKline plc
• Merck KGaA
• Novartis AG
• Bayer, F. Hoffmann-La Roche Ltd
• Zydus Group
• Sanofi Mankind Pharma Cipla Ltd
• Ipca Laboratories Ltd.
KEY BREAKDOWN: Antiparasitic Drugs Market
By Drug Type:
• Anthelmintics
• Antiprotozoals
• Others
By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Others
By Route Of Administration:
• Oral
• Injectables
• Topical
Geographical Exploration:
• North America
o The USA
o Canada
o Mexico
• Europe
o Germany
o France
o U.K.
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Middle East and Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa

1. Research Methodology
1.1. Global Antiparasitic Drugs Market Snapshot, 2023 and 2030
1.2. Data Mining
1.3. Validation
1.4. Primary Interviews
1.5. List of Data Sources
1.6. Future Market Projections
1.7. Industry Developments and Key Market Events
2. Executive Summary
3. Market Overview
3.1. Market Scope and Definition
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunity
3.2.4. Challenges
3.2.5. Cumulative Impact due to Recent Energy Crisis
3.2.6. Cumulative Impact due to Nearing Economic Downturn
3.2.7. Post Covid-19 World Supply & Demand Conditions
3.2.8. Cumulative Impact of Russia-Ukraine Conflict
3.2.9. Key Trends
3.3. Antiparasitic Drugs Market: Value Chain
3.3.1. List of Raw Material Supplier
3.3.2. List of Manufacturers
3.3.3. List of Distribution Channels
3.4. Porter Five Force’s Analysis
3.5. Regulatory and Technology Landscape
4. Global Antiparasitic Drugs Market Outlook: Forecast (2023 – 2030)
4.1. Key Highlights
4.1.1. Market Size and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Current Market Size Forecast, 2023–2030
4.3. Global Antiparasitic Drugs Market Outlook: Drug Type
4.3.1. Introduction / Key Findings
4.3.2. Market Size (US$ Mn) and Forecast Drug Type, 2023 – 2030
4.3.2.1. Anthelmintics
4.3.2.2. Antiprotozoals
4.3.2.3. Others
4.4. Global Antiparasitic Drugs Market Outlook: Distribution Channel
4.4.1. Introduction / Key Findings
4.4.2. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
4.4.2.1. Hospital Pharmacies
4.4.2.2. Retail Pharmacies
4.4.2.3. Others
4.5. Global Antiparasitic Drugs Market Outlook: Route Of Administration
4.5.1. Introduction / Key Findings
4.5.2. Market Size (US$ Mn) and Forecast By Route Of Administration, 2023 – 2030
4.5.3. Oral
4.5.4. Injectables
4.5.5. Topical.
5. Global Antiparasitic Drugs Market Outlook: Region
5.1. Key Highlights
5.2. Market Size (US$ Mn) and Forecast By Region, 2023 – 2030
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Latin America
5.2.5. Middle East & Africa (MEA)
6. North America Antiparasitic Drugs Market Outlook: Forecast (2023 – 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2022
6.3.1. By Country
6.3.2. By Drug Type
6.3.3. By Distribution Channel
6.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
6.4.1. U.S.
6.4.2. Canada
6.4.3. Mexico
6.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
6.5.1. Anthelmintics
6.5.2. Antiprotozoals
6.5.3. Others
6.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
6.6.1. Hospital Pharmacies
6.6.2. Retail Pharmacies
6.6.3. Others
6.7. Market Size (US$ Mn) and Forecast By Route Of Administration, 2023 – 2030
6.7.1. Oral
6.7.2. Injectables
6.7.3. Topical
7. Europe Antiparasitic Drugs Market Outlook: Forecast (2023 – 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
7.3.1. By Country
7.3.2. By Drug Type
7.3.3. By Distribution Channel
7.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Russia
7.4.5. Italy
7.4.6. Spain
7.4.7. Rest of Europe
7.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
7.5.1. Anthelmintics
7.5.2. Antiprotozoals
7.5.3. Others
7.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
7.6.1. Hospital Pharmacies
7.6.2. Retail Pharmacies
7.6.3. Others
7.7. Market Size (US$ Mn) and Forecast By Route Of Administration, 2023 – 2030
7.7.1. Oral
7.7.2. Injectables
7.7.3. Topical
8. Asia Pacific Antiparasitic Drugs Market Outlook: Forecast (2023 – 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
8.3.1. By Country
8.3.2. By Drug Type
8.3.3. By Distribution Channel
8.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. New Zealand
8.4.7. Singapore
8.4.8. Malaysia
8.4.9. Rest of Asia
8.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
8.5.1. Anthelmintics
8.5.2. Antiprotozoals
8.5.3. Others
8.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
8.6.1. Hospital Pharmacies
8.6.2. Retail Pharmacies
8.6.3. Others
8.7. Market Size (US$ Mn) and Forecast By Route Of Administration, 2023 – 2030
8.7.1. Oral
8.7.2. Injectables
8.7.3. Topical
9. Latin America Antiparasitic Drugs Market Outlook: Forecast (2023 – 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
9.3.1. By Country
9.3.2. By Drug Type
9.3.3. By Distribution Channel
9.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.4.4. Peru
9.4.5. Chile
9.4.6. Venezuela
9.4.7. Rest of Latin America
9.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
9.5.1. Anthelmintics
9.5.2. Antiprotozoals
9.5.3. Others
9.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
9.6.1. Hospital Pharmacies
9.6.2. Retail Pharmacies
9.6.3. Others
9.7. Market Size (US$ Mn) and Forecast By Route Of Administration, 2023 – 2030
9.7.1. Oral
9.7.2. Injectables
9.7.3. Topical
10. Middle East & Africa Antiparasitic Drugs Market Outlook: Forecast (2023 – 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2023 – 2030
10.3.1. By Country
10.3.2. By Drug Type
10.3.3. By Distribution Channel
10.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
10.4.1. Saudi Arabia
10.4.2. UAE
10.4.3. Egypt
10.4.4. Kuwait
10.4.5. South Africa
10.4.6. Rest of Middle East & Africa
10.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
10.5.1. Anthelmintics
10.5.2. Antiprotozoals
10.5.3. Others
10.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
10.6.1. Hospital Pharmacies
10.6.2. Retail Pharmacies
10.6.3. Others
10.7. Market Size (US$ Mn) and Forecast By Route Of Administration, 2023 – 2030
10.7.1. Oral
10.7.2. Injectables
10.7.3. Topical
11. Competition Analysis
11.1. Market Share Analysis Of Top Vendors
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Key Development Strategies
11.3. Company Profiles
11.3.1. Ipca Laboratories Ltd.
11.3.1.1. Overview
11.3.1.2. Offerings
11.3.1.3. Business Segment & Geographic Overview
11.3.1.4. Key Financials
11.3.1.5. Key Market Developments
11.3.1.6. Key Market Strategy
11.3.2. GlaxoSmithKline plc
11.3.3. Merck KGaA
11.3.4. Novartis AG
11.3.5. Bayer, F. Hoffmann-La Roche Ltd
11.3.6. Zydus Group
11.3.7. Sanofi Mankind Pharma Cipla Ltd
11.3.8. Ipca Laboratories Ltd